nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Microtubule Inhibition—Cabazitaxel—prostate cancer	0.379	0.707	CiPCiCtD
Ixabepilone—Microtubule Inhibition—Docetaxel—prostate cancer	0.157	0.293	CiPCiCtD
Ixabepilone—CYP3A4—prostate cancer	0.0381	1	CbGaD
Ixabepilone—TUBB2A—Cabazitaxel—prostate cancer	0.0259	0.084	CbGbCtD
Ixabepilone—TUBB8—Cabazitaxel—prostate cancer	0.0259	0.084	CbGbCtD
Ixabepilone—TUBB6—Cabazitaxel—prostate cancer	0.0259	0.084	CbGbCtD
Ixabepilone—TUBB2B—Cabazitaxel—prostate cancer	0.0259	0.084	CbGbCtD
Ixabepilone—TUBB3—Cabazitaxel—prostate cancer	0.0259	0.084	CbGbCtD
Ixabepilone—TUBB4A—Cabazitaxel—prostate cancer	0.0259	0.084	CbGbCtD
Ixabepilone—TUBB4B—Cabazitaxel—prostate cancer	0.0217	0.0703	CbGbCtD
Ixabepilone—TUBB1—Cabazitaxel—prostate cancer	0.0217	0.0703	CbGbCtD
Ixabepilone—TUBB—Cabazitaxel—prostate cancer	0.0217	0.0703	CbGbCtD
Ixabepilone—TUBB8—Docetaxel—prostate cancer	0.00869	0.0282	CbGbCtD
Ixabepilone—TUBB4A—Docetaxel—prostate cancer	0.00869	0.0282	CbGbCtD
Ixabepilone—TUBB2B—Docetaxel—prostate cancer	0.00869	0.0282	CbGbCtD
Ixabepilone—TUBB3—Docetaxel—prostate cancer	0.00869	0.0282	CbGbCtD
Ixabepilone—TUBB2A—Docetaxel—prostate cancer	0.00869	0.0282	CbGbCtD
Ixabepilone—TUBB6—Docetaxel—prostate cancer	0.00869	0.0282	CbGbCtD
Ixabepilone—TUBB1—Docetaxel—prostate cancer	0.00727	0.0236	CbGbCtD
Ixabepilone—TUBB4B—Docetaxel—prostate cancer	0.00727	0.0236	CbGbCtD
Ixabepilone—TUBB—Docetaxel—prostate cancer	0.00727	0.0236	CbGbCtD
Ixabepilone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00287	0.00931	CbGbCtD
Ixabepilone—CYP3A4—Bicalutamide—prostate cancer	0.00151	0.00489	CbGbCtD
Ixabepilone—CYP3A4—Estramustine—prostate cancer	0.0014	0.00455	CbGbCtD
Ixabepilone—CYP3A4—Flutamide—prostate cancer	0.00125	0.00405	CbGbCtD
Ixabepilone—CYP3A4—Abiraterone—prostate cancer	0.00125	0.00405	CbGbCtD
Ixabepilone—CYP3A4—Cabazitaxel—prostate cancer	0.000924	0.003	CbGbCtD
Ixabepilone—CYP3A4—Estrone—prostate cancer	0.000903	0.00293	CbGbCtD
Ixabepilone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000805	0.00261	CbGbCtD
Ixabepilone—TUBB8—testis—prostate cancer	0.000701	0.0412	CbGeAlD
Ixabepilone—TUBB4A—prostate gland—prostate cancer	0.000661	0.0388	CbGeAlD
Ixabepilone—TUBB2B—prostate gland—prostate cancer	0.000639	0.0375	CbGeAlD
Ixabepilone—TUBB—prostate gland—prostate cancer	0.000605	0.0355	CbGeAlD
Ixabepilone—TUBB2A—prostate gland—prostate cancer	0.000601	0.0353	CbGeAlD
Ixabepilone—TUBB6—prostate gland—prostate cancer	0.000593	0.0348	CbGeAlD
Ixabepilone—CYP3A4—Conjugated Estrogens—prostate cancer	0.000591	0.00192	CbGbCtD
Ixabepilone—CYP3A4—urine—prostate cancer	0.00059	0.0346	CbGeAlD
Ixabepilone—TUBB1—bone marrow—prostate cancer	0.000547	0.0321	CbGeAlD
Ixabepilone—TUBB2B—seminal vesicle—prostate cancer	0.00054	0.0317	CbGeAlD
Ixabepilone—CYP3A4—Mitoxantrone—prostate cancer	0.000537	0.00174	CbGbCtD
Ixabepilone—CYP3A4—Estradiol—prostate cancer	0.000519	0.00168	CbGbCtD
Ixabepilone—TUBB4B—prostate gland—prostate cancer	0.000516	0.0303	CbGeAlD
Ixabepilone—TUBB—seminal vesicle—prostate cancer	0.000511	0.03	CbGeAlD
Ixabepilone—TUBB2A—seminal vesicle—prostate cancer	0.000509	0.0299	CbGeAlD
Ixabepilone—TUBB6—seminal vesicle—prostate cancer	0.000502	0.0294	CbGeAlD
Ixabepilone—TUBB3—testis—prostate cancer	0.000479	0.0281	CbGeAlD
Ixabepilone—TUBB1—testis—prostate cancer	0.000468	0.0275	CbGeAlD
Ixabepilone—TUBB4A—renal system—prostate cancer	0.000451	0.0264	CbGeAlD
Ixabepilone—CYP3A4—Prednisone—prostate cancer	0.000446	0.00145	CbGbCtD
Ixabepilone—TUBB4B—seminal vesicle—prostate cancer	0.000436	0.0256	CbGeAlD
Ixabepilone—TUBB6—epithelium—prostate cancer	0.000436	0.0256	CbGeAlD
Ixabepilone—TUBB2B—renal system—prostate cancer	0.000436	0.0256	CbGeAlD
Ixabepilone—TUBB2B—urethra—prostate cancer	0.000428	0.0251	CbGeAlD
Ixabepilone—TUBB—urethra—prostate cancer	0.000405	0.0238	CbGeAlD
Ixabepilone—TUBB6—renal system—prostate cancer	0.000404	0.0237	CbGeAlD
Ixabepilone—TUBB2A—urethra—prostate cancer	0.000403	0.0236	CbGeAlD
Ixabepilone—TUBB6—urethra—prostate cancer	0.000397	0.0233	CbGeAlD
Ixabepilone—TUBB4B—renal system—prostate cancer	0.000351	0.0206	CbGeAlD
Ixabepilone—TUBB4B—urethra—prostate cancer	0.000345	0.0203	CbGeAlD
Ixabepilone—CYP3A4—Etoposide—prostate cancer	0.000339	0.0011	CbGbCtD
Ixabepilone—TUBB—bone marrow—prostate cancer	0.000312	0.0183	CbGeAlD
Ixabepilone—TUBB2A—bone marrow—prostate cancer	0.00031	0.0182	CbGeAlD
Ixabepilone—CYP3A4—Docetaxel—prostate cancer	0.00031	0.00101	CbGbCtD
Ixabepilone—TUBB6—bone marrow—prostate cancer	0.000306	0.0179	CbGeAlD
Ixabepilone—TUBB4A—testis—prostate cancer	0.000291	0.0171	CbGeAlD
Ixabepilone—TUBB2B—testis—prostate cancer	0.000281	0.0165	CbGeAlD
Ixabepilone—TUBB6—Fulvestrant—Estradiol—prostate cancer	0.000276	0.395	CbGdCrCtD
Ixabepilone—TUBB—testis—prostate cancer	0.000266	0.0156	CbGeAlD
Ixabepilone—TUBB4B—bone marrow—prostate cancer	0.000266	0.0156	CbGeAlD
Ixabepilone—TUBB2A—testis—prostate cancer	0.000265	0.0155	CbGeAlD
Ixabepilone—TUBB6—testis—prostate cancer	0.000261	0.0153	CbGeAlD
Ixabepilone—TUBB6—Levorphanol—Estrone—prostate cancer	0.000241	0.344	CbGdCrCtD
Ixabepilone—CYP3A4—Doxorubicin—prostate cancer	0.000231	0.00075	CbGbCtD
Ixabepilone—TUBB4B—testis—prostate cancer	0.000227	0.0133	CbGeAlD
Ixabepilone—TUBB4A—lymph node—prostate cancer	0.000211	0.0124	CbGeAlD
Ixabepilone—TUBB2B—lymph node—prostate cancer	0.000204	0.012	CbGeAlD
Ixabepilone—TUBB—lymph node—prostate cancer	0.000193	0.0113	CbGeAlD
Ixabepilone—TUBB2A—lymph node—prostate cancer	0.000192	0.0113	CbGeAlD
Ixabepilone—TUBB6—lymph node—prostate cancer	0.000189	0.0111	CbGeAlD
Ixabepilone—TUBB6—Levorphanol—Estradiol—prostate cancer	0.000182	0.261	CbGdCrCtD
Ixabepilone—TUBB4B—lymph node—prostate cancer	0.000165	0.00966	CbGeAlD
Ixabepilone—CYP3A4—renal system—prostate cancer	0.000144	0.00847	CbGeAlD
Ixabepilone—Stomatitis—Epirubicin—prostate cancer	1.8e-05	0.00028	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—prostate cancer	1.8e-05	0.00028	CcSEcCtD
Ixabepilone—Constipation—Etoposide—prostate cancer	1.8e-05	0.000279	CcSEcCtD
Ixabepilone—Pain—Etoposide—prostate cancer	1.8e-05	0.000279	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—prostate cancer	1.8e-05	0.000279	CcSEcCtD
Ixabepilone—Dizziness—Estradiol—prostate cancer	1.8e-05	0.000279	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—prostate cancer	1.79e-05	0.000279	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—prostate cancer	1.78e-05	0.000277	CcSEcCtD
Ixabepilone—Chest pain—Capecitabine—prostate cancer	1.77e-05	0.000274	CcSEcCtD
Ixabepilone—Arthralgia—Capecitabine—prostate cancer	1.77e-05	0.000274	CcSEcCtD
Ixabepilone—Myalgia—Capecitabine—prostate cancer	1.77e-05	0.000274	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.75e-05	0.000272	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Epirubicin—prostate cancer	1.75e-05	0.000272	CcSEcCtD
Ixabepilone—Oedema—Docetaxel—prostate cancer	1.75e-05	0.000272	CcSEcCtD
Ixabepilone—Infection—Docetaxel—prostate cancer	1.74e-05	0.00027	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—prostate cancer	1.74e-05	0.00027	CcSEcCtD
Ixabepilone—Diarrhoea—Mitoxantrone—prostate cancer	1.73e-05	0.000269	CcSEcCtD
Ixabepilone—Vomiting—Estradiol—prostate cancer	1.73e-05	0.000268	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—prostate cancer	1.72e-05	0.000267	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Etoposide—prostate cancer	1.72e-05	0.000267	CcSEcCtD
Ixabepilone—Shock—Docetaxel—prostate cancer	1.72e-05	0.000267	CcSEcCtD
Ixabepilone—Nervous system disorder—Docetaxel—prostate cancer	1.72e-05	0.000266	CcSEcCtD
Ixabepilone—Thrombocytopenia—Docetaxel—prostate cancer	1.71e-05	0.000266	CcSEcCtD
Ixabepilone—Rash—Estradiol—prostate cancer	1.71e-05	0.000266	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—prostate cancer	1.71e-05	0.000266	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—prostate cancer	1.71e-05	0.000266	CcSEcCtD
Ixabepilone—Dermatitis—Estradiol—prostate cancer	1.71e-05	0.000266	CcSEcCtD
Ixabepilone—Anaemia—Prednisone—prostate cancer	1.71e-05	0.000265	CcSEcCtD
Ixabepilone—Headache—Estradiol—prostate cancer	1.7e-05	0.000264	CcSEcCtD
Ixabepilone—Skin disorder—Docetaxel—prostate cancer	1.7e-05	0.000264	CcSEcCtD
Ixabepilone—Oedema—Capecitabine—prostate cancer	1.69e-05	0.000263	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—prostate cancer	1.68e-05	0.000261	CcSEcCtD
Ixabepilone—Infection—Capecitabine—prostate cancer	1.68e-05	0.000261	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—prostate cancer	1.68e-05	0.000261	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—prostate cancer	1.67e-05	0.000259	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—prostate cancer	1.67e-05	0.000259	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—prostate cancer	1.67e-05	0.000259	CcSEcCtD
Ixabepilone—Anorexia—Docetaxel—prostate cancer	1.67e-05	0.000259	CcSEcCtD
Ixabepilone—Shock—Capecitabine—prostate cancer	1.67e-05	0.000259	CcSEcCtD
Ixabepilone—Abdominal pain—Etoposide—prostate cancer	1.66e-05	0.000258	CcSEcCtD
Ixabepilone—Body temperature increased—Etoposide—prostate cancer	1.66e-05	0.000258	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—prostate cancer	1.66e-05	0.000258	CcSEcCtD
Ixabepilone—Nervous system disorder—Capecitabine—prostate cancer	1.66e-05	0.000258	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—prostate cancer	1.66e-05	0.000258	CcSEcCtD
Ixabepilone—Thrombocytopenia—Capecitabine—prostate cancer	1.66e-05	0.000257	CcSEcCtD
Ixabepilone—Syncope—Prednisone—prostate cancer	1.66e-05	0.000257	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—prostate cancer	1.65e-05	0.000257	CcSEcCtD
Ixabepilone—Skin disorder—Capecitabine—prostate cancer	1.64e-05	0.000255	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—prostate cancer	1.64e-05	0.000255	CcSEcCtD
Ixabepilone—Hypotension—Docetaxel—prostate cancer	1.63e-05	0.000254	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—prostate cancer	1.63e-05	0.000253	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—prostate cancer	1.63e-05	0.000253	CcSEcCtD
Ixabepilone—Loss of consciousness—Prednisone—prostate cancer	1.62e-05	0.000252	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—prostate cancer	1.62e-05	0.000251	CcSEcCtD
Ixabepilone—Anorexia—Capecitabine—prostate cancer	1.61e-05	0.000251	CcSEcCtD
Ixabepilone—Nausea—Estradiol—prostate cancer	1.61e-05	0.00025	CcSEcCtD
Ixabepilone—Vomiting—Mitoxantrone—prostate cancer	1.61e-05	0.00025	CcSEcCtD
Ixabepilone—Rash—Mitoxantrone—prostate cancer	1.6e-05	0.000248	CcSEcCtD
Ixabepilone—Dermatitis—Mitoxantrone—prostate cancer	1.59e-05	0.000248	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.59e-05	0.000247	CcSEcCtD
Ixabepilone—Headache—Mitoxantrone—prostate cancer	1.59e-05	0.000246	CcSEcCtD
Ixabepilone—Hypotension—Capecitabine—prostate cancer	1.58e-05	0.000246	CcSEcCtD
Ixabepilone—Insomnia—Docetaxel—prostate cancer	1.58e-05	0.000246	CcSEcCtD
Ixabepilone—Arthralgia—Prednisone—prostate cancer	1.57e-05	0.000244	CcSEcCtD
Ixabepilone—Myalgia—Prednisone—prostate cancer	1.57e-05	0.000244	CcSEcCtD
Ixabepilone—Paraesthesia—Docetaxel—prostate cancer	1.57e-05	0.000244	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—prostate cancer	1.57e-05	0.000244	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.56e-05	0.000243	CcSEcCtD
Ixabepilone—Dyspnoea—Docetaxel—prostate cancer	1.56e-05	0.000242	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—prostate cancer	1.55e-05	0.000241	CcSEcCtD
Ixabepilone—Hypersensitivity—Etoposide—prostate cancer	1.55e-05	0.000241	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—prostate cancer	1.54e-05	0.00024	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.54e-05	0.00024	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—prostate cancer	1.54e-05	0.000239	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—prostate cancer	1.54e-05	0.000239	CcSEcCtD
Ixabepilone—Insomnia—Capecitabine—prostate cancer	1.53e-05	0.000238	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—prostate cancer	1.53e-05	0.000237	CcSEcCtD
Ixabepilone—Paraesthesia—Capecitabine—prostate cancer	1.52e-05	0.000236	CcSEcCtD
Ixabepilone—Decreased appetite—Docetaxel—prostate cancer	1.52e-05	0.000236	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—prostate cancer	1.52e-05	0.000236	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Docetaxel—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Asthenia—Etoposide—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Dyspnoea—Capecitabine—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Oedema—Prednisone—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Fatigue—Docetaxel—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—prostate cancer	1.51e-05	0.000234	CcSEcCtD
Ixabepilone—Nausea—Mitoxantrone—prostate cancer	1.5e-05	0.000233	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—prostate cancer	1.5e-05	0.000233	CcSEcCtD
Ixabepilone—Infection—Prednisone—prostate cancer	1.5e-05	0.000233	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—prostate cancer	1.5e-05	0.000232	CcSEcCtD
Ixabepilone—Pain—Docetaxel—prostate cancer	1.5e-05	0.000232	CcSEcCtD
Ixabepilone—Constipation—Docetaxel—prostate cancer	1.5e-05	0.000232	CcSEcCtD
Ixabepilone—Chills—Epirubicin—prostate cancer	1.49e-05	0.000231	CcSEcCtD
Ixabepilone—Pruritus—Etoposide—prostate cancer	1.49e-05	0.000231	CcSEcCtD
Ixabepilone—Shock—Prednisone—prostate cancer	1.48e-05	0.00023	CcSEcCtD
Ixabepilone—Nervous system disorder—Prednisone—prostate cancer	1.48e-05	0.00023	CcSEcCtD
Ixabepilone—Decreased appetite—Capecitabine—prostate cancer	1.47e-05	0.000229	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—prostate cancer	1.47e-05	0.000228	CcSEcCtD
Ixabepilone—Skin disorder—Prednisone—prostate cancer	1.47e-05	0.000228	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Capecitabine—prostate cancer	1.46e-05	0.000227	CcSEcCtD
Ixabepilone—Fatigue—Capecitabine—prostate cancer	1.46e-05	0.000227	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—prostate cancer	1.45e-05	0.000226	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—prostate cancer	1.45e-05	0.000226	CcSEcCtD
Ixabepilone—Pain—Capecitabine—prostate cancer	1.45e-05	0.000225	CcSEcCtD
Ixabepilone—Constipation—Capecitabine—prostate cancer	1.45e-05	0.000225	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—prostate cancer	1.45e-05	0.000224	CcSEcCtD
Ixabepilone—Diarrhoea—Etoposide—prostate cancer	1.44e-05	0.000224	CcSEcCtD
Ixabepilone—Anorexia—Prednisone—prostate cancer	1.44e-05	0.000223	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—prostate cancer	1.44e-05	0.000223	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Docetaxel—prostate cancer	1.43e-05	0.000222	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—prostate cancer	1.43e-05	0.000221	CcSEcCtD
Ixabepilone—Angiopathy—Doxorubicin—prostate cancer	1.39e-05	0.000216	CcSEcCtD
Ixabepilone—Dizziness—Etoposide—prostate cancer	1.39e-05	0.000216	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—prostate cancer	1.39e-05	0.000216	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—prostate cancer	1.39e-05	0.000216	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Capecitabine—prostate cancer	1.38e-05	0.000215	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—prostate cancer	1.38e-05	0.000215	CcSEcCtD
Ixabepilone—Body temperature increased—Docetaxel—prostate cancer	1.38e-05	0.000215	CcSEcCtD
Ixabepilone—Abdominal pain—Docetaxel—prostate cancer	1.38e-05	0.000215	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—prostate cancer	1.38e-05	0.000214	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Prednisone—prostate cancer	1.37e-05	0.000213	CcSEcCtD
Ixabepilone—Insomnia—Prednisone—prostate cancer	1.36e-05	0.000212	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—prostate cancer	1.36e-05	0.000211	CcSEcCtD
Ixabepilone—Paraesthesia—Prednisone—prostate cancer	1.35e-05	0.00021	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—prostate cancer	1.35e-05	0.000209	CcSEcCtD
Ixabepilone—Abdominal pain—Capecitabine—prostate cancer	1.34e-05	0.000208	CcSEcCtD
Ixabepilone—Body temperature increased—Capecitabine—prostate cancer	1.34e-05	0.000208	CcSEcCtD
Ixabepilone—Vomiting—Etoposide—prostate cancer	1.34e-05	0.000208	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—prostate cancer	1.34e-05	0.000208	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—prostate cancer	1.34e-05	0.000207	CcSEcCtD
Ixabepilone—Rash—Etoposide—prostate cancer	1.33e-05	0.000206	CcSEcCtD
Ixabepilone—Dermatitis—Etoposide—prostate cancer	1.33e-05	0.000206	CcSEcCtD
Ixabepilone—Headache—Etoposide—prostate cancer	1.32e-05	0.000205	CcSEcCtD
Ixabepilone—Decreased appetite—Prednisone—prostate cancer	1.31e-05	0.000204	CcSEcCtD
Ixabepilone—Fatigue—Prednisone—prostate cancer	1.3e-05	0.000202	CcSEcCtD
Ixabepilone—Syncope—Epirubicin—prostate cancer	1.3e-05	0.000201	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—prostate cancer	1.29e-05	0.000201	CcSEcCtD
Ixabepilone—Constipation—Prednisone—prostate cancer	1.29e-05	0.0002	CcSEcCtD
Ixabepilone—Hypersensitivity—Docetaxel—prostate cancer	1.29e-05	0.0002	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—prostate cancer	1.29e-05	0.0002	CcSEcCtD
Ixabepilone—Loss of consciousness—Epirubicin—prostate cancer	1.27e-05	0.000197	CcSEcCtD
Ixabepilone—Cough—Epirubicin—prostate cancer	1.26e-05	0.000196	CcSEcCtD
Ixabepilone—Asthenia—Docetaxel—prostate cancer	1.25e-05	0.000195	CcSEcCtD
Ixabepilone—Nausea—Etoposide—prostate cancer	1.25e-05	0.000194	CcSEcCtD
Ixabepilone—Hypersensitivity—Capecitabine—prostate cancer	1.25e-05	0.000194	CcSEcCtD
Ixabepilone—Pruritus—Docetaxel—prostate cancer	1.24e-05	0.000192	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—prostate cancer	1.24e-05	0.000192	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Prednisone—prostate cancer	1.23e-05	0.000192	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—prostate cancer	1.23e-05	0.000191	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—prostate cancer	1.23e-05	0.000191	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—prostate cancer	1.23e-05	0.000191	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.22e-05	0.00019	CcSEcCtD
Ixabepilone—Asthenia—Capecitabine—prostate cancer	1.22e-05	0.000189	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—prostate cancer	1.2e-05	0.000186	CcSEcCtD
Ixabepilone—Pruritus—Capecitabine—prostate cancer	1.2e-05	0.000186	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—prostate cancer	1.2e-05	0.000186	CcSEcCtD
Ixabepilone—Diarrhoea—Docetaxel—prostate cancer	1.2e-05	0.000186	CcSEcCtD
Ixabepilone—Body temperature increased—Prednisone—prostate cancer	1.19e-05	0.000185	CcSEcCtD
Ixabepilone—Abdominal pain—Prednisone—prostate cancer	1.19e-05	0.000185	CcSEcCtD
Ixabepilone—Oedema—Epirubicin—prostate cancer	1.18e-05	0.000183	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—prostate cancer	1.18e-05	0.000183	CcSEcCtD
Ixabepilone—Infection—Epirubicin—prostate cancer	1.17e-05	0.000182	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—prostate cancer	1.17e-05	0.000181	CcSEcCtD
Ixabepilone—Shock—Epirubicin—prostate cancer	1.16e-05	0.00018	CcSEcCtD
Ixabepilone—Diarrhoea—Capecitabine—prostate cancer	1.16e-05	0.00018	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—prostate cancer	1.16e-05	0.00018	CcSEcCtD
Ixabepilone—Dizziness—Docetaxel—prostate cancer	1.16e-05	0.00018	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—prostate cancer	1.16e-05	0.000179	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—prostate cancer	1.15e-05	0.000178	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—prostate cancer	1.14e-05	0.000177	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—prostate cancer	1.14e-05	0.000177	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—prostate cancer	1.14e-05	0.000177	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.13e-05	0.000176	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—prostate cancer	1.12e-05	0.000175	CcSEcCtD
Ixabepilone—Dizziness—Capecitabine—prostate cancer	1.12e-05	0.000174	CcSEcCtD
Ixabepilone—Vomiting—Docetaxel—prostate cancer	1.11e-05	0.000173	CcSEcCtD
Ixabepilone—Hypersensitivity—Prednisone—prostate cancer	1.11e-05	0.000173	CcSEcCtD
Ixabepilone—Rash—Docetaxel—prostate cancer	1.1e-05	0.000171	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—prostate cancer	1.1e-05	0.000171	CcSEcCtD
Ixabepilone—Dermatitis—Docetaxel—prostate cancer	1.1e-05	0.000171	CcSEcCtD
Ixabepilone—Headache—Docetaxel—prostate cancer	1.1e-05	0.00017	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—prostate cancer	1.09e-05	0.00017	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—prostate cancer	1.08e-05	0.000168	CcSEcCtD
Ixabepilone—Asthenia—Prednisone—prostate cancer	1.08e-05	0.000168	CcSEcCtD
Ixabepilone—Vomiting—Capecitabine—prostate cancer	1.08e-05	0.000167	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.07e-05	0.000167	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—prostate cancer	1.07e-05	0.000167	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—prostate cancer	1.07e-05	0.000166	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—prostate cancer	1.07e-05	0.000166	CcSEcCtD
Ixabepilone—Rash—Capecitabine—prostate cancer	1.07e-05	0.000166	CcSEcCtD
Ixabepilone—Pruritus—Prednisone—prostate cancer	1.07e-05	0.000166	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—prostate cancer	1.07e-05	0.000166	CcSEcCtD
Ixabepilone—Dermatitis—Capecitabine—prostate cancer	1.07e-05	0.000166	CcSEcCtD
Ixabepilone—Headache—Capecitabine—prostate cancer	1.06e-05	0.000165	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—prostate cancer	1.06e-05	0.000165	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—prostate cancer	1.06e-05	0.000165	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—prostate cancer	1.05e-05	0.000163	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—prostate cancer	1.04e-05	0.000162	CcSEcCtD
Ixabepilone—Nausea—Docetaxel—prostate cancer	1.04e-05	0.000161	CcSEcCtD
Ixabepilone—Diarrhoea—Prednisone—prostate cancer	1.03e-05	0.00016	CcSEcCtD
Ixabepilone—Decreased appetite—Epirubicin—prostate cancer	1.03e-05	0.000159	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—prostate cancer	1.02e-05	0.000158	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—prostate cancer	1.02e-05	0.000158	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—prostate cancer	1.02e-05	0.000158	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—prostate cancer	1.01e-05	0.000157	CcSEcCtD
Ixabepilone—Pain—Epirubicin—prostate cancer	1.01e-05	0.000157	CcSEcCtD
Ixabepilone—Nausea—Capecitabine—prostate cancer	1.01e-05	0.000156	CcSEcCtD
Ixabepilone—Dizziness—Prednisone—prostate cancer	9.98e-06	0.000155	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.95e-06	0.000154	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—prostate cancer	9.87e-06	0.000153	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—prostate cancer	9.8e-06	0.000152	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—prostate cancer	9.73e-06	0.000151	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—prostate cancer	9.65e-06	0.00015	CcSEcCtD
Ixabepilone—Vomiting—Prednisone—prostate cancer	9.59e-06	0.000149	CcSEcCtD
Ixabepilone—Rash—Prednisone—prostate cancer	9.51e-06	0.000148	CcSEcCtD
Ixabepilone—Dermatitis—Prednisone—prostate cancer	9.5e-06	0.000148	CcSEcCtD
Ixabepilone—Decreased appetite—Doxorubicin—prostate cancer	9.49e-06	0.000147	CcSEcCtD
Ixabepilone—Headache—Prednisone—prostate cancer	9.45e-06	0.000147	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.42e-06	0.000146	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—prostate cancer	9.41e-06	0.000146	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—prostate cancer	9.33e-06	0.000145	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—prostate cancer	9.33e-06	0.000145	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—prostate cancer	9.33e-06	0.000145	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—prostate cancer	9.33e-06	0.000145	CcSEcCtD
Ixabepilone—Nausea—Prednisone—prostate cancer	8.96e-06	0.000139	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Doxorubicin—prostate cancer	8.93e-06	0.000139	CcSEcCtD
Ixabepilone—Hypersensitivity—Epirubicin—prostate cancer	8.69e-06	0.000135	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—prostate cancer	8.63e-06	0.000134	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—prostate cancer	8.63e-06	0.000134	CcSEcCtD
Ixabepilone—Asthenia—Epirubicin—prostate cancer	8.46e-06	0.000131	CcSEcCtD
Ixabepilone—Pruritus—Epirubicin—prostate cancer	8.35e-06	0.00013	CcSEcCtD
Ixabepilone—Diarrhoea—Epirubicin—prostate cancer	8.07e-06	0.000125	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—prostate cancer	8.04e-06	0.000125	CcSEcCtD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—PPARA—prostate cancer	7.89e-06	0.000225	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	7.87e-06	0.000225	CbGpPWpGaD
Ixabepilone—Asthenia—Doxorubicin—prostate cancer	7.83e-06	0.000122	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—prostate cancer	7.8e-06	0.000121	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—ATM—prostate cancer	7.79e-06	0.000223	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	7.76e-06	0.000222	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—RXRA—prostate cancer	7.76e-06	0.000222	CbGpPWpGaD
Ixabepilone—Pruritus—Doxorubicin—prostate cancer	7.72e-06	0.00012	CcSEcCtD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	7.71e-06	0.00022	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	7.63e-06	0.000218	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTA4—prostate cancer	7.63e-06	0.000218	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—PPARA—prostate cancer	7.62e-06	0.000218	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	7.61e-06	0.000218	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TYMS—prostate cancer	7.54e-06	0.000215	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	7.53e-06	0.000215	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—prostate cancer	7.5e-06	0.000116	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	7.49e-06	0.000214	CbGpPWpGaD
Ixabepilone—Diarrhoea—Doxorubicin—prostate cancer	7.47e-06	0.000116	CcSEcCtD
Ixabepilone—Rash—Epirubicin—prostate cancer	7.44e-06	0.000116	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTA2—prostate cancer	7.44e-06	0.000212	CbGpPWpGaD
Ixabepilone—Dermatitis—Epirubicin—prostate cancer	7.43e-06	0.000115	CcSEcCtD
Ixabepilone—Headache—Epirubicin—prostate cancer	7.39e-06	0.000115	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—PLAUR—prostate cancer	7.39e-06	0.000211	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—PPARA—prostate cancer	7.38e-06	0.000211	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	7.35e-06	0.00021	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	7.24e-06	0.000207	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—prostate cancer	7.22e-06	0.000112	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—PPARA—prostate cancer	7.21e-06	0.000206	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TERT—prostate cancer	7.18e-06	0.000205	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTA1—prostate cancer	7.17e-06	0.000205	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NAT2—prostate cancer	7.09e-06	0.000203	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTO1—prostate cancer	7.09e-06	0.000203	CbGpPWpGaD
Ixabepilone—Nausea—Epirubicin—prostate cancer	7.01e-06	0.000109	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	7e-06	0.0002	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	7e-06	0.0002	CbGpPWpGaD
Ixabepilone—Vomiting—Doxorubicin—prostate cancer	6.94e-06	0.000108	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—prostate cancer	6.88e-06	0.000107	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—prostate cancer	6.88e-06	0.000107	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—prostate cancer	6.84e-06	0.000106	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—LEP—prostate cancer	6.8e-06	0.000194	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—LEP—prostate cancer	6.8e-06	0.000194	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	6.8e-06	0.000194	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	6.71e-06	0.000192	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—LEP—prostate cancer	6.57e-06	0.000188	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TERT—prostate cancer	6.57e-06	0.000188	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—prostate cancer	6.48e-06	0.000101	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—PPARA—prostate cancer	6.48e-06	0.000185	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—ATM—prostate cancer	6.45e-06	0.000184	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—LEP—prostate cancer	6.36e-06	0.000182	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	6.32e-06	0.000181	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.26e-06	0.000179	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.26e-06	0.000179	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	6.25e-06	0.000179	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	6.24e-06	0.000178	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—LEP—prostate cancer	6.22e-06	0.000178	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.05e-06	0.000173	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	5.95e-06	0.00017	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—PPARA—prostate cancer	5.92e-06	0.000169	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—ATM—prostate cancer	5.9e-06	0.000169	CbGpPWpGaD
Ixabepilone—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	5.89e-06	0.000168	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1B—prostate cancer	5.87e-06	0.000168	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.86e-06	0.000167	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—INS—prostate cancer	5.81e-06	0.000166	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—INS—prostate cancer	5.81e-06	0.000166	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MDM2—prostate cancer	5.75e-06	0.000164	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.73e-06	0.000164	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—HPGDS—prostate cancer	5.67e-06	0.000162	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	5.64e-06	0.000161	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGF1—prostate cancer	5.62e-06	0.000161	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGF1—prostate cancer	5.62e-06	0.000161	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—INS—prostate cancer	5.61e-06	0.00016	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—prostate cancer	5.6e-06	0.00016	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—LEP—prostate cancer	5.59e-06	0.00016	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	5.56e-06	0.000159	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTT1—prostate cancer	5.5e-06	0.000157	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MMP2—prostate cancer	5.44e-06	0.000155	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MMP2—prostate cancer	5.44e-06	0.000155	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	5.44e-06	0.000155	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—INS—prostate cancer	5.44e-06	0.000155	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—IGF1—prostate cancer	5.43e-06	0.000155	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1A—prostate cancer	5.42e-06	0.000155	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—INS—prostate cancer	5.32e-06	0.000152	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—IGF1—prostate cancer	5.26e-06	0.00015	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MMP2—prostate cancer	5.25e-06	0.00015	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1B—prostate cancer	5.25e-06	0.00015	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	5.22e-06	0.000149	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	5.21e-06	0.000149	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—EP300—prostate cancer	5.15e-06	0.000147	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.14e-06	0.000147	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—IGF1—prostate cancer	5.14e-06	0.000147	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	5.14e-06	0.000147	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—LEP—prostate cancer	5.11e-06	0.000146	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—MMP2—prostate cancer	5.09e-06	0.000145	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—prostate cancer	5.01e-06	0.000143	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—MMP2—prostate cancer	4.98e-06	0.000142	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NCOA2—prostate cancer	4.96e-06	0.000142	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1B—prostate cancer	4.86e-06	0.000139	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1A—prostate cancer	4.84e-06	0.000138	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—INS—prostate cancer	4.77e-06	0.000136	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MDM2—prostate cancer	4.76e-06	0.000136	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.7e-06	0.000134	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—prostate cancer	4.64e-06	0.000133	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	4.62e-06	0.000132	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGF1—prostate cancer	4.62e-06	0.000132	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—EP300—prostate cancer	4.61e-06	0.000132	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	4.56e-06	0.00013	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CXCL8—prostate cancer	4.52e-06	0.000129	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CXCL8—prostate cancer	4.52e-06	0.000129	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—prostate cancer	4.49e-06	0.000128	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1A—prostate cancer	4.49e-06	0.000128	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MMP2—prostate cancer	4.47e-06	0.000128	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1B—prostate cancer	4.45e-06	0.000127	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	4.38e-06	0.000125	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CXCL8—prostate cancer	4.37e-06	0.000125	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—INS—prostate cancer	4.36e-06	0.000125	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MDM2—prostate cancer	4.36e-06	0.000124	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1B—prostate cancer	4.35e-06	0.000124	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	4.32e-06	0.000124	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—EP300—prostate cancer	4.27e-06	0.000122	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GGT1—prostate cancer	4.24e-06	0.000121	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—prostate cancer	4.24e-06	0.000121	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CXCL8—prostate cancer	4.23e-06	0.000121	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGF1—prostate cancer	4.22e-06	0.000121	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NCOA1—prostate cancer	4.18e-06	0.000119	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTNNB1—prostate cancer	4.17e-06	0.000119	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTNNB1—prostate cancer	4.17e-06	0.000119	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—prostate cancer	4.15e-06	0.000119	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CXCL8—prostate cancer	4.13e-06	0.000118	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	4.12e-06	0.000118	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1A—prostate cancer	4.11e-06	0.000117	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MMP2—prostate cancer	4.09e-06	0.000117	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	4.06e-06	0.000116	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTNNB1—prostate cancer	4.03e-06	0.000115	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—prostate cancer	4.02e-06	0.000115	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1A—prostate cancer	4.01e-06	0.000115	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1B—prostate cancer	3.98e-06	0.000114	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—RXRA—prostate cancer	3.98e-06	0.000114	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—EP300—prostate cancer	3.91e-06	0.000112	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTNNB1—prostate cancer	3.9e-06	0.000111	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—COMT—prostate cancer	3.83e-06	0.000109	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—EP300—prostate cancer	3.82e-06	0.000109	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTNNB1—prostate cancer	3.81e-06	0.000109	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—prostate cancer	3.81e-06	0.000109	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—prostate cancer	3.79e-06	0.000108	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	3.78e-06	0.000108	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	3.76e-06	0.000107	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—prostate cancer	3.72e-06	0.000106	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CXCL8—prostate cancer	3.71e-06	0.000106	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1A—prostate cancer	3.67e-06	0.000105	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTM1—prostate cancer	3.5e-06	0.0001	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—EP300—prostate cancer	3.49e-06	9.98e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	3.46e-06	9.87e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTNNB1—prostate cancer	3.42e-06	9.79e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—prostate cancer	3.4e-06	9.73e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CXCL8—prostate cancer	3.4e-06	9.7e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—prostate cancer	3.33e-06	9.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	3.32e-06	9.49e-05	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—prostate cancer	3.3e-06	9.42e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HAO1—prostate cancer	3.28e-06	9.37e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	3.28e-06	9.36e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTNNB1—prostate cancer	3.13e-06	8.95e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—prostate cancer	3.04e-06	8.7e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—prostate cancer	2.73e-06	7.81e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TST—prostate cancer	2.67e-06	7.64e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GRHL1—prostate cancer	2.67e-06	7.64e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ADI1—prostate cancer	2.67e-06	7.64e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CBR1—prostate cancer	2.67e-06	7.64e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CSAD—prostate cancer	2.67e-06	7.64e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PSAT1—prostate cancer	2.67e-06	7.64e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—prostate cancer	2.5e-06	7.14e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UGT2B15—prostate cancer	2.48e-06	7.1e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UGT2B17—prostate cancer	2.48e-06	7.1e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CKMT2—prostate cancer	2.48e-06	7.1e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GRHPR—prostate cancer	2.48e-06	7.1e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PGAM2—prostate cancer	2.34e-06	6.67e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NAGLU—prostate cancer	2.34e-06	6.67e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—RFK—prostate cancer	2.34e-06	6.67e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SULT2B1—prostate cancer	2.34e-06	6.67e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTM3—prostate cancer	2.34e-06	6.67e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MBTPS1—prostate cancer	2.34e-06	6.67e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AOX1—prostate cancer	2.34e-06	6.67e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP3A43—prostate cancer	2.21e-06	6.33e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AMACR—prostate cancer	2.21e-06	6.33e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NAT1—prostate cancer	2.21e-06	6.33e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—DEGS1—prostate cancer	2.21e-06	6.33e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SRD5A2—prostate cancer	2.21e-06	6.33e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HSD17B1—prostate cancer	2.11e-06	6.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.88e-06	5.38e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HPGD—prostate cancer	1.88e-06	5.38e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.77e-06	5.06e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.72e-06	4.92e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTAP—prostate cancer	1.72e-06	4.92e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.68e-06	4.8e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.68e-06	4.8e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ACSL4—prostate cancer	1.6e-06	4.57e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.6e-06	4.57e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PHGDH—prostate cancer	1.53e-06	4.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ARG2—prostate cancer	1.53e-06	4.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UMPS—prostate cancer	1.53e-06	4.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—LDHB—prostate cancer	1.51e-06	4.3e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.48e-06	4.22e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TCN2—prostate cancer	1.43e-06	4.08e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PDHA1—prostate cancer	1.43e-06	4.08e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UCP3—prostate cancer	1.43e-06	4.08e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA3—prostate cancer	1.43e-06	4.08e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.36e-06	3.89e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.36e-06	3.89e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.31e-06	3.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA4—prostate cancer	1.31e-06	3.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA2—prostate cancer	1.27e-06	3.63e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.26e-06	3.59e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCG5—prostate cancer	1.26e-06	3.59e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA1—prostate cancer	1.23e-06	3.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTO1—prostate cancer	1.21e-06	3.47e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NAT2—prostate cancer	1.21e-06	3.47e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.21e-06	3.47e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PLCB2—prostate cancer	1.16e-06	3.32e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—LRP2—prostate cancer	1.16e-06	3.32e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.16e-06	3.32e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—P4HB—prostate cancer	1.14e-06	3.26e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.11e-06	3.17e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.08e-06	3.09e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MED12—prostate cancer	1.06e-06	3.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GNG5—prostate cancer	1.06e-06	3.02e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.02e-06	2.91e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HPGDS—prostate cancer	9.7e-07	2.77e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP2C19—prostate cancer	9.64e-07	2.75e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTT1—prostate cancer	9.41e-07	2.69e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ACHE—prostate cancer	9.41e-07	2.69e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP2A6—prostate cancer	9.3e-07	2.66e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKR1C3—prostate cancer	9.05e-07	2.58e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PRKACB—prostate cancer	9e-07	2.57e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP17A1—prostate cancer	8.9e-07	2.54e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOA2—prostate cancer	8.49e-07	2.42e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC5A5—prostate cancer	8.09e-07	2.31e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP2E1—prostate cancer	7.91e-07	2.26e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NQO1—prostate cancer	7.82e-07	2.23e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TH—prostate cancer	7.71e-07	2.2e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1B1—prostate cancer	7.5e-07	2.14e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GGT1—prostate cancer	7.26e-07	2.07e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOA1—prostate cancer	7.15e-07	2.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.05e-07	2.01e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—RXRA—prostate cancer	6.8e-07	1.94e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—COMT—prostate cancer	6.55e-07	1.87e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—prostate cancer	6.52e-07	1.86e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ITPR1—prostate cancer	6.42e-07	1.83e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMS—prostate cancer	6.06e-07	1.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTM1—prostate cancer	5.99e-07	1.71e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—LPL—prostate cancer	5.88e-07	1.68e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.68e-07	1.62e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ERCC2—prostate cancer	5.63e-07	1.61e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTHFR—prostate cancer	5.3e-07	1.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPARA—prostate cancer	5.2e-07	1.48e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CAV1—prostate cancer	4.88e-07	1.4e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.45e-07	1.27e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—INS—prostate cancer	4.21e-07	1.2e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CREBBP—prostate cancer	4.13e-07	1.18e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.91e-07	1.12e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NOS3—prostate cancer	3.69e-07	1.06e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.41e-07	9.74e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—prostate cancer	3.38e-07	9.65e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—prostate cancer	2.95e-07	8.42e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—EP300—prostate cancer	2.81e-07	8.03e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.08e-07	5.94e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—prostate cancer	1.7e-07	4.85e-06	CbGpPWpGaD
